| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 88 |
| 1 | ACETAMINOPHEN | 53 |
| 2 | CAPECITABINE | 53 |
| 3 | DEXAMETHASONE | 53 |
| 4 | DEXAMETHASONE 1.5 MG | 53 |
| 5 | FUROSEMIDE | 53 |
| 6 | ASPIRIN | 50 |
| 7 | ASPIRIN 325 MG | 50 |
| 8 | ASPIRIN 81 MG | 50 |
| 9 | PACLITAXEL | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE HCL, MENTHOL | 2 | 0.0588 |
| 1 | COAGULATION FACTOR X HUMAN | 1 | 0.0286 |
| 2 | CIPAGLUCOSIDASE ALFA-ATGA | 1 | 0.0110 |
| 3 | MEBROFENIN | 1 | 0.0109 |
| 4 | BEVACIZUMAB-MALY | 2 | 0.0100 |
| 5 | ESTRONE | 1 | 0.0093 |
| 6 | SINCALIDE | 1 | 0.0065 |
| 7 | ESOMEPRAZOLE SODIUM | 14 | 0.0057 |
| 8 | PEGFILGRASTIM-APGF | 1 | 0.0051 |
| 9 | FUTIBATINIB | 1 | 0.0045 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 146 |
| 1 | Corticosteroid [EPC] | 135 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 127 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 90 |
| 4 | Proton Pump Inhibitor [EPC] | 71 |
| 5 | Kinase Inhibitor [EPC] | 67 |
| 6 | Microtubule Inhibitor [EPC] | 57 |
| 7 | Loop Diuretic [EPC] | 55 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 52 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 16 | 0.0018 |
| 4 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 5 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 6 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 7 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 8 | Human Immunoglobulin G [EPC] | 15 | 0.0007 |
| 9 | Non-narcotic Antitussive [EPC] | 11 | 0.0007 |